The global hemodialysis concentrates and powders market is expected to grow at a CAGR of 4.5% during the forecast period, to reach USD 1.2 billion by 2030. The growth of this market is driven by factors such as increasing prevalence of chronic kidney disease, rising incidence of cardiovascular diseases, and growing geriatric population. Hemodialysis concentrates are used for the treatment of acute or chronic renal failure in patients with end-stage renal disease (ESRD). Hemodialysis dry powder is used for the treatment of acute or chronic renal failure in patients with ESRD who are not on dialysis yet but have been diagnosed with kidney disease. Private clinics accounted for the largest share in 2017 owing to their high adoption rate among hospitals and nursing homes due to their cost-effectiveness and easy availability. North America was the largest regional market in 2017 due to its high prevalence rates for chronic kidney diseases, cardiovascular diseases, and geriatric population which drives demand for hemodialysis concentrates & powders products from private clinics as well as public hospitals across this region.
Some Of The Growth Factors Of This Market:
- The global Hemodialysis Concentrates & Powders market is driven by factors such as increasing prevalence of chronic kidney disease and rising incidence of cardiovascular diseases, which are major causes for renal failure and subsequent need for hemodialysis treatment.
- Increasing number of patients with end-stage renal disease (ESRD) is also driving the growth of the global Hemodialysis Concentrates & Powders market.
- Increasing awareness about hemodialysis treatment among patients suffering from chronic kidney disease and other related disorders is also driving the growth of the global Hemodialysis Concentrates & Powders market.
- Lack of skilled professionals in developing countries such as India, China, Brazil, Mexico etc, to provide hemodialysis treatment services to patients suffering from chronic kidney disease and other related disorders is restraining the growth rate in these regions.
Industry Growth Insights published a new data on “Hemodialysis Concentrates & Powders Market”. The research report is titled “Hemodialysis Concentrates & Powders Market research by Types (Hemodialysis Concentrates, Hemodialysis Dry Powder), By Applications (Private Clinic, Public Hospital, Personal Care, Nursing Home, Others), By Players/Companies Fresenius, B. Braun, Renacon Pharma, Chief Medical Supplies, Farmasol, Weigao, Tianjin ever -trust medical, Jiangxi Sanxin Medtec, Baxter, Rockwell Medical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Hemodialysis Concentrates & Powders Market Research Report
By Type
Hemodialysis Concentrates, Hemodialysis Dry Powder
By Application
Private Clinic, Public Hospital, Personal Care, Nursing Home, Others
By Companies
Fresenius, B. Braun, Renacon Pharma, Chief Medical Supplies, Farmasol, Weigao, Tianjin ever -trust medical, Jiangxi Sanxin Medtec, Baxter, Rockwell Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Hemodialysis Concentrates & Powders Market Report Segments:
The global Hemodialysis Concentrates & Powders market is segmented on the basis of:
Types
Hemodialysis Concentrates, Hemodialysis Dry Powder
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Private Clinic, Public Hospital, Personal Care, Nursing Home, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Fresenius
- B. Braun
- Renacon Pharma
- Chief Medical Supplies
- Farmasol
- Weigao
- Tianjin ever -trust medical
- Jiangxi Sanxin Medtec
- Baxter
- Rockwell Medical
Highlights of The Hemodialysis Concentrates & Powders Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hemodialysis Concentrates
- Hemodialysis Dry Powder
- By Application:
- Private Clinic
- Public Hospital
- Personal Care
- Nursing Home
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hemodialysis Concentrates & Powders Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hemodialysis concentrates and powders are a type of dialysis treatment that helps to clean the blood. They are made from the waste products left over after hemodialysis treatments.
Some of the major companies in the hemodialysis concentrates & powders market are Fresenius, B. Braun, Renacon Pharma, Chief Medical Supplies, Farmasol, Weigao, Tianjin ever -trust medical, Jiangxi Sanxin Medtec, Baxter, Rockwell Medical.
The hemodialysis concentrates & powders market is expected to register a CAGR of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Hemodialysis Concentrates & Powders Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Hemodialysis Concentrates & Powders Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Hemodialysis Concentrates & Powders Market - Supply Chain
4.5. Global Hemodialysis Concentrates & Powders Market Forecast
4.5.1. Hemodialysis Concentrates & Powders Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Hemodialysis Concentrates & Powders Market Size (000 Units) and Y-o-Y Growth
4.5.3. Hemodialysis Concentrates & Powders Market Absolute $ Opportunity
5. Global Hemodialysis Concentrates & Powders Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Hemodialysis Concentrates & Powders Market Size and Volume Forecast by Type
5.3.1. Hemodialysis Concentrates
5.3.2. Hemodialysis Dry Powder
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Hemodialysis Concentrates & Powders Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Hemodialysis Concentrates & Powders Market Size and Volume Forecast by Application
6.3.1. Private Clinic
6.3.2. Public Hospital
6.3.3. Personal Care
6.3.4. Nursing Home
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Hemodialysis Concentrates & Powders Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Hemodialysis Concentrates & Powders Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Hemodialysis Concentrates & Powders Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Hemodialysis Concentrates & Powders Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Hemodialysis Concentrates & Powders Demand Share Forecast, 2019-2026
9. North America Hemodialysis Concentrates & Powders Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Hemodialysis Concentrates & Powders Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Hemodialysis Concentrates & Powders Market Size and Volume Forecast by Application
9.4.1. Private Clinic
9.4.2. Public Hospital
9.4.3. Personal Care
9.4.4. Nursing Home
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Hemodialysis Concentrates & Powders Market Size and Volume Forecast by Type
9.7.1. Hemodialysis Concentrates
9.7.2. Hemodialysis Dry Powder
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Hemodialysis Concentrates & Powders Demand Share Forecast, 2019-2026
10. Latin America Hemodialysis Concentrates & Powders Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Hemodialysis Concentrates & Powders Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Hemodialysis Concentrates & Powders Market Size and Volume Forecast by Application
10.4.1. Private Clinic
10.4.2. Public Hospital
10.4.3. Personal Care
10.4.4. Nursing Home
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Hemodialysis Concentrates & Powders Market Size and Volume Forecast by Type
10.7.1. Hemodialysis Concentrates
10.7.2. Hemodialysis Dry Powder
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Hemodialysis Concentrates & Powders Demand Share Forecast, 2019-2026
11. Europe Hemodialysis Concentrates & Powders Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Hemodialysis Concentrates & Powders Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Hemodialysis Concentrates & Powders Market Size and Volume Forecast by Application
11.4.1. Private Clinic
11.4.2. Public Hospital
11.4.3. Personal Care
11.4.4. Nursing Home
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Hemodialysis Concentrates & Powders Market Size and Volume Forecast by Tpe
11.7.1. Hemodialysis Concentrates
11.7.2. Hemodialysis Dry Powder
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Hemodialysis Concentrates & Powders Demand Share, 2019-2026
12. Asia Pacific Hemodialysis Concentrates & Powders Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Hemodialysis Concentrates & Powders Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Hemodialysis Concentrates & Powders Market Size and Volume Forecast by Application
12.4.1. Private Clinic
12.4.2. Public Hospital
12.4.3. Personal Care
12.4.4. Nursing Home
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Hemodialysis Concentrates & Powders Market Size and Volume Forecast by Type
12.7.1. Hemodialysis Concentrates
12.7.2. Hemodialysis Dry Powder
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Hemodialysis Concentrates & Powders Demand Share, 2019-2026
13. Middle East & Africa Hemodialysis Concentrates & Powders Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Hemodialysis Concentrates & Powders Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Hemodialysis Concentrates & Powders Market Size and Volume Forecast by Application
13.4.1. Private Clinic
13.4.2. Public Hospital
13.4.3. Personal Care
13.4.4. Nursing Home
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Hemodialysis Concentrates & Powders Market Size and Volume Forecast by Type
13.7.1. Hemodialysis Concentrates
13.7.2. Hemodialysis Dry Powder
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Hemodialysis Concentrates & Powders Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Hemodialysis Concentrates & Powders Market: Market Share Analysis
14.2. Hemodialysis Concentrates & Powders Distributors and Customers
14.3. Hemodialysis Concentrates & Powders Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Fresenius
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. B. Braun
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Renacon Pharma
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Chief Medical Supplies
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Farmasol
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Weigao
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Tianjin ever -trust medical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Jiangxi Sanxin Medtec
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Baxter
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Rockwell Medical
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook